Opthea Announces Completion of Drug Substance PPQ Campaign Validating Manufacturing Process of Sozinibercept
September 18, 2024 07:30 ET
|
Opthea Limited
Three consecutive commercial-scale batches successfully produced Major milestone for potential BLA filing of sozinibercept in wet AMD Progress update of drug product PPQ campaign expected in...
Plus Therapeutics Showcases New Interim ReSPECT-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual Meeting
September 18, 2024 07:30 ET
|
Plus Therapeutics Inc.
Plus Therapeutics Showcases New Interim ReSPECT-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual Meeting
Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures
September 18, 2024 07:00 ET
|
Revive Therapeutics Ltd.
TORONTO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research...
Triamcinolone Market to Reach $1.3 Billion, Globally, by 2033 at 3.8% CAGR: Allied Market Research
September 18, 2024 06:28 ET
|
Allied Analytics LLP
Wilmington, Delaware, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Triamcinolone Market by Type (Cream, Injection and Inhalers), Application (Eczema,...
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference
September 18, 2024 06:00 ET
|
Zymeworks Inc.
VANCOUVER, British Columbia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME) a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...
ImCheck Receives FDA Fast Track Designation for ICT01 in Combination with Azacitidine and Venetoclax in First-Line Acute Myeloid Leukemia for Patients Unfit for Induction Chemotherapy Treatment
September 18, 2024 05:00 ET
|
ImCheck Therapeutics SAS
ImCheck Receives FDA Fast Track Designation for ICT01in Combination with Azacitidine and Venetoclaxin First-Line Acute Myeloid Leukemiafor Patients Unfit for Induction Chemotherapy Treatment ICT01,...
Anthony Agoshkov & Ilya Max Launch Alchemy Family: The Exclusive Networking Club for Financial Leaders, Pioneering Growth Through Deep Connections
September 18, 2024 02:13 ET
|
Alchemy Family
Dubai, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Anthony Agoshkov, founder of Marvel Capital, alongside co-founder Ilya Max, announces the launch of Alchemy Family, a private members-only club, exclusively...
KFSHRC impulsa el surgimiento de Arabia Saudita como potencia mundial de biotecnología
September 17, 2024 20:53 ET
|
King Faisal Specialist Hospital & Research Centre
RIAD, Arabia Saudita, Sept. 17, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) lidera los esfuerzos de Arabia Saudita para convertirse en una potencia...
KFSHRC Impulsiona Ascensão da Arábia Saudita como Potência Mundial de Biotecnologia
September 17, 2024 20:53 ET
|
King Faisal Specialist Hospital & Research Centre
RIADE, Arábia Saudita, Sept. 17, 2024 (GLOBE NEWSWIRE) -- O King Faisal Specialist Hospital& Research Centre (KFSH&RC) está liderando o esforço da Arábia Saudita de se tornar uma...
Rodale Institute Partners With California Farmers to Transition to Regenerative Organic Farming with $1 Million Investment from Holdfast Collective, Patagonia’s Non Profit Shareholder
September 17, 2024 14:45 ET
|
Rodale Institute™
CAMARILLO, Ca., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Rodale Institute, the global leader in regenerative organic agriculture, has received $1M from Holdfast Collective, Patagonia’s non profit...